Logo

Charles River to Use Advion s NanoMate System for Proteomics Research

Mar 02, 2004

NEW YORK, March 2 (GenomeWeb News) - Charles River Proteomic Services (CRPS) has purchased Advion Biosciences' NanoMate 100 protein identification technology, the companies said today.

Financial terms of the agreement were not disclosed.

The NanoMate 100 is an automated chip-based nanoelectrospray system for peptide mass fingerprinting. Advion said the system also offers capabilities for identifying biomarkers and protein-protein interactions.

John Pirro, general manager of CRPS, said the company is "currently exploring" the technology's performance "with respect to biomarker validation/discovery, post translational modifications of proteins, and increased de novo sequencing capabilities."

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.